Spirea Limited
Spirea Limited, a Cambridge-based startup working to develop a new generation of antibody-drug conjugate (ADC) treatments
Spirea Limited has raised €2.8M across 1 funding round, most recently a round in Jun 2022. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.spirea.co.uk ↗
Total raised
€2.8M
€2,772,067
Funding rounds
1
Investors
0
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearSpirea Limited — funding by year — interactive chart.
Data table
| Spirea Limited — funding by year | |
|---|---|
| 2022 | €2.8M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-14 | Other | €2.8M | — | View deal → |
Related news
- Female-led British biotech raises £2.4M to develop ‘smart bomb’ like drugs to kill cancer cells techfundingnews.com · 2022-06
Similar companies
same sector or countryGlobal coverage: FundingData